Insulet makes Omnipod 5 available with Dexcom G7 15 Day CGM

Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 Day CGM.

Drug Delivery Business News, reports that the companies now offer the integrated solution following Dexcom’s full launch for its latest sensor.

Acton, Massachusetts-based Insulet, which has paired its pumps with previous versions of Dexcom continuous glucose monitors (CGMs), has offered Omnipod 5 with the initial version of G7 since early 2024. However, Dexcom received FDA clearance for people over the age of 18 years old in the U.S. in April for the 15-day version of its latest-generation sensor.

Sign up for Blog Updates